Roivant Sciences Ltd.
ROIV- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001635088
In the last 90 days, Roivant Sciences Ltd. insiders filed 0 open-market purchases and 7 sales; 500 institutions reported holding it in 13F filings for Q2 2026, worth $19.7B in total; 3 superinvestors hold it, including Viking Global Investors and Maverick Capital.
13F holders, Q2 2025
Institutional positions in Roivant Sciences Ltd. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 339
- +26 vs. Q1 2025
- Shares held
- 514.5M
- −43.1M (−7.7%) vs. Q1 2025
- Total value
- $5.80B
- +$171.7M (+3.1%) vs. Q1 2025
- New holders
- 61
- 115 more added
- Sold out
- 35
- 109 more reduced
1 institution that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ROIV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 500 | $19.7B |
| Q1 2026 | 445 | $14.7B |
| Q4 2025 | 400 | $11.0B |
| Q3 2025 | 338 | $7.59B |
| Q2 2025 | 339 | $5.80B |
| Q1 2025 | 314 | $5.63B |
| Q4 2024 | 320 | $6.65B |
| Q3 2024 | 294 | $6.57B |
| Q2 2024 | 294 | $5.77B |
| Q1 2024 | 259 | $5.60B |
| Q4 2023 | 225 | $6.08B |
| Q3 2023 | 207 | $6.38B |
| Q2 2023 | 182 | $5.03B |
| Q1 2023 | 147 | $3.39B |
| Q4 2022 | 110 | $3.29B |
| Q3 2022 | 78 | $1.19B |
| Q2 2022 | 71 | $1.47B |
| Q1 2022 | 52 | $1.72B |
| Q4 2021 | 42 | $3.42B |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Roivant Sciences Ltd.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| ADAR1 Capital Management, LLC | 1,940,797 | $21.9M | 3.55% | −1,542,607−44.3% | Reduced |
| Impax Asset Management Group plc | 2,000,000 | $22.5M | 0.13% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 2,082,383 | $23.5M | 0.04% | −1,737,600−45.5% | Reduced |
| Loomis Sayles & Co L P | 2,105,409 | $23.7M | 0.03% | −352,443−14.3% | Reduced |
| Barclays PLC | 2,114,867 | $23.8M | 0.01% | +605,951+40.2% | Added |
| Squarepoint Ops LLC | 2,211,675 | $24.9M | 0.05% | +2,129,150+2,580.0% | Added |
| Nuveen, LLC | 2,281,526 | $25.7M | 0.01% | −888,760−28.0% | Reduced |
| PointState Capital LP | 2,426,563 | $27.3M | 0.59% | −288,560−10.6% | Reduced |
| Bank of America Corp | 2,652,043 | $29.9M | 0.00% | +331,829+14.3% | Added |
| UBS Asset Management Americas Inc | 2,775,349 | $31.3M | 0.01% | +329,542+13.5% | Added |
| OrbiMed Advisors LLC | 2,779,427 | $31.3M | 0.79% | +2,779,427 | New |
| Charles Schwab Investment Management Inc | 2,889,082 | $32.6M | 0.01% | +41,457+1.5% | Added |
| Goldman Sachs Group Inc | 2,937,367 | $33.1M | 0.01% | +503,981+20.7% | Added |
| Point72 Asset Management, L.P. | 2,951,132 | $33.3M | 0.08% | +2,336,817+380.4% | Added |
| Sofinnova Investments, Inc. | 3,088,814 | $34.8M | 2.37% | +1,809,304+141.4% | Added |
| Pertento Partners LLP | 3,104,361 | $35.0M | 3.95% | −520,252−14.4% | Reduced |
| Northern Trust Corp | 3,233,214 | $36.4M | 0.01% | −68,085−2.1% | Reduced |
| Perceptive Advisors LLC | 3,331,465 | $37.5M | 1.41% | +3,331,465 | New |
| Baker Bros. Advisors LP | 3,767,773 | $42.5M | 0.41% | 00.0% | Unchanged |
| Whitefort Capital Management, LP | 3,882,000 | $43.8M | 16.92% | +471,000+13.8% | Added |
| Woodline Partners LP | 4,000,033 | $45.1M | 0.24% | −1,253,323−23.9% | Reduced |
| Bank of New York Mellon Corp | 4,506,400 | $50.8M | 0.01% | +506,219+12.7% | Added |
| DME Capital Management, LPSuperinvestorGreenlight Capital | 4,551,057 | $51.3M | 2.21% | −890,110−16.4% | Reduced |
| BlackBarn Capital Partners LP | 4,625,000 | $52.1M | 17.27% | −125,000−2.6% | Reduced |
| Anchorage Capital Group, L.L.C. | 4,832,642 | $54.5M | 21.05% | 00.0% | Unchanged |
| UBS Group AG | 5,093,068 | $57.4M | 0.01% | −1,704,135−25.1% | Reduced |
| Geode Capital Management, LLC | 7,750,399 | $87.4M | 0.01% | −216,986−2.7% | Reduced |
| Dimensional Fund Advisors LP | 7,885,636 | $88.9M | 0.02% | +5,297,818+204.7% | Added |
| Two Seas Capital LP | 10,598,040 | $119.4M | 11.71% | +461,733+4.6% | Added |
| Patient Square Capital LP | 12,480,000 | $140.6M | 50.71% | 00.0% | Unchanged |
| State Street Corp | 19,773,480 | $222.8M | 0.01% | +911,827+4.8% | Added |
| Rubric Capital Management LP | 20,370,336 | $229.6M | 3.69% | +2,603,260+14.7% | Added |
| QVT Financial LP | 29,381,635 | $331.1M | 46.25% | −36,412,144−55.3% | Reduced |
| Viking Global Investors LPSuperinvestorViking Global Investors | 34,237,779 | $385.9M | 1.12% | −11,775,973−25.6% | Reduced |
| Vanguard Group Inc | 39,326,336 | $443.2M | 0.01% | −1,441,254−3.5% | Reduced |
| BlackRock, Inc. | 40,316,307 | $454.4M | 0.01% | −1,343,181−3.2% | Reduced |
| Morgan Stanley | 44,693,966 | $503.7M | 0.03% | +8,767,207+24.4% | Added |
| FMR LLC | 55,509,281 | $625.6M | 0.04% | +3,842,770+7.4% | Added |
| SB Investment Advisers (UK) Ltd | 59,952,652 | $675.7M | 5.36% | −1,900,066−3.1% | Reduced |
| TOMS Capital Investment Management LP | 0 | $0 | 0.00% | −4,095,000−100.0% | Sold out |
| Tyro Capital Management LLC | 0 | $0 | 0.00% | −2,465,377−100.0% | Sold out |
| Cutter Capital Management, LP | 0 | $0 | 0.00% | −1,300,000−100.0% | Sold out |
| Zimmer Partners, LP | 0 | $0 | 0.00% | −534,500−100.0% | Sold out |
| Melqart Asset Management (UK) Ltd | 0 | $0 | 0.00% | −502,584−100.0% | Sold out |
| Corebridge Financial, Inc. | 0 | $0 | 0.00% | −464,990−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −256,714−100.0% | Sold out |
| Rangeley Capital, LLC | 0 | $0 | 0.00% | −140,178−100.0% | Sold out |
| Clearline Capital LP | 0 | $0 | 0.00% | −120,000−100.0% | Sold out |
| Monaco Asset Management SAM | 0 | $0 | 0.00% | −120,000−100.0% | Sold out |
| Bayesian Capital Management, LP | 0 | $0 | 0.00% | −51,000−100.0% | Sold out |
| De Lisle Partners LLP | 0 | $0 | 0.00% | −50,000−100.0% | Sold out |
| SIH Partners, LLLP | 0 | $0 | 0.00% | −44,403−100.0% | Sold out |
| UBS Oconnor LLC | 0 | $0 | 0.00% | −42,819−100.0% | Sold out |
| Blue Owl Capital Holdings LP | 0 | $0 | 0.00% | −39,003−100.0% | Sold out |
| Wexford Capital LP | 0 | $0 | 0.00% | −37,000−100.0% | Sold out |
| Mariner, LLC | 0 | $0 | 0.00% | −35,621−100.0% | Sold out |
| United Services Automobile Association | 0 | $0 | 0.00% | −27,494−100.0% | Sold out |
| Capula Management Ltd | 0 | $0 | 0.00% | −27,574−100.0% | Sold out |
| 111 Capital | 0 | $0 | 0.00% | −26,536−100.0% | Sold out |
| Catalyst Funds Management Pty Ltd | 0 | $0 | 0.00% | −23,440−100.0% | Sold out |
| Stifel Financial Corp | 0 | $0 | 0.00% | −21,863−100.0% | Sold out |
| Greenwich Wealth Management LLC | 0 | $0 | 0.00% | −15,945−100.0% | Sold out |
| Diametric Capital, LP | 0 | $0 | 0.00% | −12,921−100.0% | Sold out |
| Quarry LP | 0 | $0 | 0.00% | −12,800−100.0% | Sold out |
| Quantessence Capital LLC | 0 | $0 | 0.00% | −12,513−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −11,644−100.0% | Sold out |
| Camden Capital, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Coldstream Capital Management Inc | 0 | $0 | 0.00% | −3,994−100.0% | Sold out |
| Boston Private Wealth LLC | 0 | $0 | 0.00% | −218−100.0% | Sold out |
| Smartleaf Asset Management LLC | 0 | $0 | 0.00% | −186−100.0% | Sold out |
| Quent Capital, LLC | 0 | $0 | 0.00% | −102−100.0% | Sold out |
| SWAN Capital LLC | 0 | $0 | 0.00% | −75−100.0% | Sold out |
| American Capital Advisory, LLC | 0 | $0 | 0.00% | −19−100.0% | Sold out |
| TFC Financial Management | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Lindbrook Capital, LLC | – | – | – | – | Not filed |